-
Edwards Lifesciences Corporation (EW $76.30)
- $76.30 P/E (TTM): 31.68X Cap: $44.75B
- View EW Profile
- View Questions on EW
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Edwards Lifesciences Corporation (EW $76.30)
- $76.30 P/E (TTM): 31.68X Cap: $44.75B
- View EW Profile
- View Questions on EW
Q: i've owned a half position in Edwards Lifesciences for several years in a basket of several important US medical companies. Certainly I see an opportunity to create a full position at these low levels. However I'm primarily a dividend investor close to retirement, and Edwards does not pay me a dividend. Is the company ever likely to pay a dividend ? What is the likely future for this company ten or twenty years out.
-
Edwards Lifesciences Corporation (EW $76.30)
- $76.30 P/E (TTM): 31.68X Cap: $44.75B
- View EW Profile
- View Questions on EW
Q: Further to Brian's question 27 July, would you take a position in EW here if you planned to hold 1+ yrs ? Thank you.
-
Edwards Lifesciences Corporation (EW $76.30)
- $76.30 P/E (TTM): 31.68X Cap: $44.75B
- View EW Profile
- View Questions on EW
Q: What are your thoughts on Edwards LifeSciences (EW) in light of the punishment it’s receiving today in the market? It’s down 29% at the time of writing (July 25). Is the reaction unjustified and a buying opportunity?
Insiders
Share Information
SEC Filings
News and Media